Key facts
- This page summarizes Brian Mueller's Form 4 filing for BIOMARIN PHARMACEUTICAL INC (BMRN).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 30 Jun 2023, 11:35.
Brian Mueller - 29 Jun 2023 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)
- Reporting relationship
- EVP, Chief Financial Officer
- Issuer ticker
- BMRN
- Reported as of
- 29 Jun 2023
- Net transaction value
- -$869,735
- SEC form
- 4
- Accepted by SEC
- 30 Jun 2023, 11:35:59 UTC
- Prior SEC filing
- 17 Mar 2023
- Next SEC filing
- 12 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Eric Fleekop, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Brian Mueller filed Form 4 for BIOMARIN PHARMACEUTICAL INC (BMRN) on 30 Jun 2023.
Change
- Previous filing in this sequence was filed on 17 Mar 2023.
- Current net transaction value: -$869,735.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BMRN
transaction
Common Stock
Tax liability
- Transaction value
- $409,256
- Shares
- -4,602
- Change %
- -8.3%
- Price
- $88.93
- Shares after
- 50,983
- Date
- 29 Jun 2023
- Ownership
- Direct
BMRN
transaction
Common Stock
Tax liability
- Transaction value
- $409,256
- Shares
- -4,602
- Change %
- -9%
- Price
- $88.93
- Shares after
- 46,381
- Date
- 29 Jun 2023
- Ownership
- Direct
BMRN
transaction
Common Stock
Tax liability
- Transaction value
- $51,224
- Shares
- -576
- Change %
- -1.2%
- Price
- $88.93
- Shares after
- 45,805
- Date
- 29 Jun 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.